Neuro65/AOCN2024

Presentation information

Oral Session

English

[O-07] Oral Session 07 [English]「Parkinsonism and Related disorders 1」

Wed. May 29, 2024 3:35 PM - 5:05 PM Room12 (G409, Glass Building, 4F, TIF)

Chair(s): Atsushi Takeda (NHO Sendai Nishitaga Hospital, Japan), Hirohisa Watanabe (Fujita Health University, Japan)

[O-07-2] Randomized placebo-controlled trial of zonisamide in at-risk subjects of Lewy body disease

Keita Hiraga1, Makoto Hattori1, Yuki Satake1,2, Daigo Tamakoshi1, Taiki Fukushima1, Maki Sato1, Katsunori Yokoi3, Keisuke Suzuki3, Yutaka Arahata3, Yoshino Ueki4, Fumie Kinoshita5, Hiroshi Matsuda6, Akihiro Murata7, Masayuki Yamamoto8, Masakazu Wakai9, Noriyuki Matsukawa4, Yukihiko Washimi3, Masahisa Katsuno1 (1.Nagoya University Graduate School of Medicine, Japan, 2.Daido Hospital, Japan, 3.National Center for Geriatrics and Gerontology, Japan, 4.Nagoya City University Graduate School of Medical Sciences, Japan, 5.Nagoya University Hospital, Japan, 6.Drug Discovery and Cyclotron Research Center, Southern TOHOKU Research Institute for Neuroscience, Japan, 7.Nihon Medi-Physics, Japan, 8.Kumiai Kosei Hospital, Japan, 9.Chutoen General Medical Center, Japan)

Abstract password authentication.
You can find the password on page 15 of the program book.

Password